Navigation Links
Genes Unlock New Treatments for Deadly Melanoma
Date:10/25/2007

Scientific Meeting Highlights New Therapies and Diagnostics,

Holding Promise for Melanoma Patients

NEW YORK, Oct. 25 /PRNewswire-USNewswire/ -- Record-high registration at the upcoming 2007 International Melanoma Congress signals new promise and hope in treating a disease that has long held a dismal prognosis for those in the advanced stages. Caught early, melanoma is one of the easiest cancers to treat, but caught late, melanoma is one of the most incurable and deadly.

This year's Congress highlights the growing understanding about the underlying genetic mutations that cause melanoma. "With each genetic mutation we successfully identify, it opens up yet another door to a new therapy," says Ze'ev Ronai, Ph.D., organizer of this year's Congress and Program Director at the Burnham Institute for Medical Research. "What's clear is that a broad-spectrum approach to treating advanced melanoma is rapidly being replaced by targeted and likely personalized therapies."

The median life expectancy for those with advanced melanoma is nine months and existing therapies have not improved survival in more than a decade. Approximately five years ago, the research community began unlocking the underlying genetic malfunctions that occur in cells, causing melanoma. Today, researchers are beginning to correlate those discoveries to therapies that may have a meaningful impact on the survival of patients.

"We're starting to understand that melanoma is actually many different diseases and that there is not one easy magic bullet that we're going to find," says Lynn Schuchter, M.D., Professor of Medicine at the Abramson Cancer Center of University of Pennsylvania. "But there is great excitement not only for the drugs in development, but also from the fact that much of the basic science being done has implications for patients now. In many cases we don't have to wait for a new drug to be developed. Drugs that are already on the market are being used to slow down disease progression."

Highlights of the Congress includes:

-- research uncovering the usefulness of an existing drug

-- promising results of Stage II and Stage III clinical trials

-- a better diagnostic tool soon to be available

-- basic research findings that will serve as a platform

for future therapies.

The Society for Melanoma Research meeting also marks a change in the Society's main scientific publication. Pigment Cell Research will become Pigment Cell and Melanoma Research to underscore the rapidly expanding potential in melanoma research, and will serve as a focal point for the international research community in discussing advances in field. A preview issue produced for the Congress will be dedicated to melanoma research. The renamed journal will be officially launched in January 2008.

The Society for Melanoma Research (SMR) is an all-volunteer group of scientists working to find the mechanisms responsible for melanoma and, consequently, new therapies for this cancer. SMR contributes to advances in melanoma research by bringing together researchers in a non-competitive way to unite the scientific community. The Society has commissioned the Roadmap for Melanoma which outlines the key targets for research and therapy that need to be addressed by 2010. http://www.melanomacongress07.net

CONTACT: Berna Diehl

703-966-3602

berna@jonespa.com


'/>"/>
SOURCE The Society for Melanoma Research
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Genes for lung disease
3. Genesis of SUPAC
4. Cirrhosis linked to genes
5. Altering genes through calories
6. Predictable genes
7. Genes for Vision discovered
8. Endometriosis coalesced with genes
9. Birth weight may be influenced by genes
10. New breast cancer genes discovered
11. Altitude sickness connected to genes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The Visiting ... Day Market. Featuring a collection of specialty vendors and unique items from across the ... and quality-focused health and wellness services offered by the VNA. The boutique will ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob ... sciatica in a new episode of "Success Files," which is an award-winning educational ... and investigates each subject in-depth with passion and integrity. , Sciatica occurs when ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... services for healthcare compliance program management, will showcase a range of technology and ... for Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 ...
(Date:10/12/2017)... ... 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the ... new design of the shoulder pad. The shoulder pad provides optimal support and ... pain while using cold therapy. By utilizing ice and water that is circulated from ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... Hair Restoration, has recently contributed a medical article to the newly revamped ... Dr. Mohebi’s article spotlights the hair transplant procedure known as Follicular Unit ...
Breaking Medicine News(10 mins):
(Date:9/18/2017)... KALAMAZOO, Mich. , Sept. 18, 2017 /PRNewswire/ ... and OptiMed Specialty Pharmacy of Kalamazoo, Mich. ... a strategic hub service that expedites and streamlines patient ... spirometer, Spiro PD 2.0, and wellness management services.  ... a medical device used to measure lung function for ...
(Date:9/12/2017)... Sept. 12, 2017   EcoVadis , the leading platform for environmental, ... first annual edition of its Global CSR Risk and Performance Index. The ... EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data points across ... ... ...
(Date:9/9/2017)... ... ... Monday, September 18 th .The Brain Tumor Foundation (BTF) begins a week-long ... BTF,s Mobile MRI Unit – a 70 Ft. ... brings its nationwide initiative, the Road to Early Detection Sponsor-A-City Campaign to ...
Breaking Medicine Technology: